Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


McKesson Will Centralize CDC Vaccine Distribution Program

This article was originally published in The Pink Sheet Daily

Executive Summary

Contract will pay McKesson up to $95 mil. over five years.

You may also be interested in...

Obama-Era Contract, Past Track Record Lands McKesson COVID-19 Vaccine Distribution Deal

The previous administration’s forethought may have given the Trump team a leg up in vaccine distribution. McKesson’s experience as a central distributor for the Vaccines for Children’s program, H1N1 and its role in seasonal flu vaccine distribution should make it well positioned to handle the COVID-19 effort in the US, experts said. 

Gardasil Catch-Up Vaccination Program Recommended By CDC Cmte.

CDC’s Advisory Committee on Immunization Practices recommends routine vaccination of girls ages 11 to 12 and a catch-up program for females ages 13 to 26 at its June 29 meeting.

Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s

Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts